Sanofi (SNY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Group 1 - The company anticipates a placeholder of around 15% for U.S. tariffs by 2025, indicating a manageable impact on operations [1] - There is no specific guidance provided for the year 2026 regarding tariffs, suggesting ongoing assessment of the situation [1] - The company has conducted scenario analysis to prepare for potential tariff impacts, indicating a proactive approach to risk management [1]